A novel anxiogenic role for the delta opioid receptor expressed in GABaergic forebrain neurons

Biological Psychiatry

Volumn 77, Issue 4, 2015, Pages 404-415

  Chung, Paul Chu Sin ^a   Keyworth, Helen L ^b   Martin Garcia, Elena ^c   Charbogne, Pauline ^e   Darcq, Emmanuel ^e   Bailey, Alexis ^b   Filliol, Dominique ^a   Matifas, Audrey ^a   Scherrer, Grégory ^d   Ouagazzal, Abdel Mouttalib ^a   Gaveriaux Ruff, Claire ^a   Befort, Katia ^a   Maldonado, Rafael ^c   Kitchen, Ian ^b   Kieffer, Brigitte L ^a,e  

^a UNIVERSITÉ DE STRASBOURG   (France)

^b UNIVERSITY OF SURREY   (United Kingdom)

^c UNIVERSITAT POMPEU FABRA   (Spain)

^d STANFORD UNIVERSITY   (United States)

^e MCGILL UNIVERSITY   (Canada)

Author keywords

Conditional gene knockout; Delta opioid receptor; Emotion; Gabaergic forebrain neurons; Locomotion; Motivation

Indexed keywords

4 AMINOBUTYRIC ACID RECEPTOR; 4 [ALPHA (4 ALLYL 2,5 DIMETHYL 1 PIPERAZINYL) 3 METHOXYBENZYL] N,N DIETHYLBENZAMIDE; 6 CHLORO 2,3,4,5 TETRAHYDRO 7,8 DIHYDROXY 1 PHENYL 1H 3 BENZAZEPINE; DELTA OPIATE RECEPTOR; PROTEIN FOS; 4-(ALPHA-(4-ALLYL-2,5-DIMETHYL-1-PIPERAZINYL)-3-METHOXYBENZYL)-N,N-DIETHYLBENZAMIDE; BENZAMIDE DERIVATIVE; BENZAZEPINE DERIVATIVE; DOPAMINE 1 RECEPTOR; DOPAMINE RECEPTOR STIMULATING AGENT; MESSENGER RNA; PIPERAZINE DERIVATIVE; PROTEIN C FOS; SK&F 81297;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANXIETY; ARTICLE; BASOLATERAL AMYGDALA; BEHAVIOR; BRAIN CORTEX; BRAIN NERVE CELL; CIRCADIAN RHYTHM; CONTROLLED STUDY; CORPUS STRIATUM; DEPRESSION; DRUG EFFECT; ELEVATED PLUS MAZE TEST; EMOTION; FEEDING; FEMALE; FOREBRAIN; HYPERACTIVITY; KNOCKOUT MOUSE; LOCOMOTION; MALE; MOUSE; MUTAGENESIS; NONHUMAN; OLFACTORY BULB; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; REWARD; SMELLING; AGONISTS; ANIMAL; ANIMAL BEHAVIOR; BRAIN; DRUG EFFECTS; GENETICS; METABOLISM; MOTIVATION; MOTOR ACTIVITY; PATHOPHYSIOLOGY; PHYSIOLOGY;

ANIMALS; ANXIETY; BEHAVIOR, ANIMAL; BENZAMIDES; BENZAZEPINES; BRAIN; CORPUS STRIATUM; DOPAMINE AGONISTS; FEMALE; GABAERGIC NEURONS; MALE; MICE; MICE, KNOCKOUT; MOTIVATION; MOTOR ACTIVITY; OLFACTORY BULB; PIPERAZINES; PROSENCEPHALON; PROTO-ONCOGENE PROTEINS C-FOS; RECEPTORS, DOPAMINE D1; RECEPTORS, OPIOID, DELTA; RNA, MESSENGER;

EID: 84922559775     PISSN: 00063223     EISSN: 18732402     Source Type: Journal    
DOI: 10.1016/j.biopsych.2014.07.033     Document Type: Article

References (66)

1. Sauriyal DS, Jaggi AS, Singh N (2011): Extending pharmacological spectrum of opioids beyond analgesia: Multifunctional aspects in different pathophysiological states. Neuropeptides 45: 175-188.
2. Lutz PE, Kieffer BL (2013): Opioid receptors: Distinct roles in mood disorders. Trends Neurosci 36:195-206.
3. Pradhan AA, Befort K, Nozaki C, Gaveriaux-Ruff C, Kieffer BL (2011): The delta opioid receptor: An evolving target for the treatment of brain disorders. Trends Pharmacol Sci 32:581-590.
4. Gaveriaux-Ruff C, Kieffer BL (2011): Delta opioid receptor analgesia: Recent contributions from pharmacology and molecular approaches. Behav Pharmacol 22:405-414.
5. Chu Sin Chung P, Kieffer BL (2013): Delta opioid receptors in brain function and diseases. Pharmacol Ther 140:112-120.
6. Filliol D, Ghozland S, Chluba J, Martin M, Matthes HW, Simonin F, et al. (2000): Mice deficient for delta- And mu-opioid receptors exhibit opposing alterations of emotional responses. Nat Genet 25: 195-200.
7. Befort K, Mahoney MK, Chow C, Hayton SJ, Kieffer BL, Olmstead MC (2011): Effects of delta opioid receptors activation on a response inhibition task in rats. Psychopharmacology (Berl) 214:967-976.
8. Le Merrer J, Faget L, Matifas A, Kieffer BL (2012): Cues predicting drug or food reward restore morphine-induced place conditioning in mice lacking delta opioid receptors. Psychopharmacology (Berl) 223: 99-106.
9. Kitchen I, Slowe SJ, Matthes HW, Kieffer B (1997): Quantitative autoradiographic mapping of mu-, delta- And kappa-opioid receptors in knockout mice lacking the mu-opioid receptor gene. Brain Res 778: 73-88.
10. Slowe SJ, Simonin F, Kieffer B, Kitchen I (1999): Quantitative autoradiography of mu-, delta- And kappa1 opioid receptors in kappaopioid receptor knockout mice. Brain Res 818:335-345.
11. Goody RJ, Oakley SM, Filliol D, Kieffer BL, Kitchen I (2002): Quantitative autoradiographic mapping of opioid receptors in the brain of delta-opioid receptor gene knockout mice. Brain Res 945: 9-19.
12. Le Merrer J, Becker JA, Befort K, Kieffer BL (2009): Reward processing by the opioid system in the brain. Physiol Rev 89:1379-1412.
13. Scherrer G, Tryoen-Toth P, Filliol D, Matifas A, Laustriat D, Cao YQ, et al. (2006): Knockin mice expressing fluorescent delta-opioid receptors uncover G protein-coupled receptor dynamics in vivo. Proc Natl Acad Sci U S A 103:9691-9696.
14. Scherrer G, Imamachi N, Cao YQ, Contet C, Mennicken F, O'Donnell D, et al. (2009): Dissociation of the opioid receptor mechanisms that control mechanical and heat pain. Cell 137:1148-1159.
15. Erbs E, Faget L, Scherrer G, Kessler P, Hentsch D, Vonesch JL, et al. (2012): Distribution of delta opioid receptor-expressing neurons in the mouse hippocampus. Neuroscience 221:203-213.
16. Rezai X, Faget L, Bednarek E, Schwab Y, Kieffer BL, Massotte D (2012): Mouse delta opioid receptors are located on presynaptic afferents to hippocampal pyramidal cells. Cell Mol Neurobiol 32: 509-516.
17. Poole DP, Pelayo JC, Scherrer G, Evans CJ, Kieffer BL, Bunnett NW (2011): Localization and regulation of fluorescently labeled delta opioid receptor, expressed in enteric neurons of mice. Gastroenterology 141:982-991.e1-e8.
18. Erbs E, Faget L, Scherrer G, Matifas A, Filliol D, Becker J, et al. (2014): A mu-delta opioid receptor brain atlas reveals co-occurrence in neurons essential for survival [published online ahead of print Mar 13]. Brain Struct Function.
19. Simonin F, Befort K, Gaveriaux-Ruff C, Matthes H, Nappey V, Lannes B, et al. (1994): The human delta opioid receptor: Genomic organization, cDNA cloning, functional expression and distribution in human brain. Mol Pharmacol 46:1015-1021.
20. Peckys D, Landwehrmeyer GB (1999): Expression of mu, kappa, and delta opioid receptor messenger RNA in the human CNS: A 33P in situ hybridization study. Neuroscience 88:1093-1135.
21. Smith JS, Zubieta JK, Price JC, Flesher JE, Madar I, Lever JR, et al. (1999): Quantification of delta-opioid receptors in human brain with N10-([11C]methyl) naltrindole and positron emission tomography. J Cereb Blood Flow Metab 19:956-966.
22. Peng J, Sarkar S, Chang SL (2012): Opioid receptor expression in human brain and peripheral tissues using absolute quantitative realtime RT-PCR. Drug Alcohol Depend 124:223-228.
23. Gaveriaux-Ruff C (2013): Opiate-induced analgesia: Contributions from mu, delta and kappa opioid receptors mouse mutants. Curr Pharm Des 19:7373-7381.
24. Gaveriaux-Ruff C, Nozaki C, Nadal X, Hever XC, Weibel R, Matifas A, et al. (2011): Genetic ablation of delta opioid receptors in nociceptive sensory neurons increases chronic pain and abolishes opioid analgesia. Pain 152:1238-1248.
25. Narita M, Kuzumaki N, Kaneko C, Hareyama N, Miyatake M, Shindo K, et al. (2006): Chronic pain-induced emotional dysfunction is associated with astrogliosis due to cortical delta-opioid receptor dysfunction. J Neurochem 97:1369-1378.
26. Solati J, Zarrindast MR, Salari AA (2010): Dorsal hippocampal opioidergic system modulates anxiety-like behaviors in adult male Wistar rats. Psychiatry Clin Neurosci 64:634-641.
27. Narita M, Kaneko C, Miyoshi K, Nagumo Y, Kuzumaki N, Nakajima M, et al. (2006): Chronic pain induces anxiety with concomitant changes in opioidergic function in the amygdala. Neuropsychopharmacology 31:739-750.
28. Randall-Thompson JF, Pescatore KA, Unterwald EM (2010): A role for delta opioid receptors in the central nucleus of the amygdala in anxiety-like behaviors. Psychopharmacology (Berl) 212:585-595.
29. Befort K, Filliol D, Ghate A, Darcq E, Matifas A, Muller J, et al. (2008): Mu-opioid receptor activation induces transcriptional plasticity in the central extended amygdala. Eur J Neurosci 27:2973-2984.
30. Livak KJ, Schmittgen TD (2001): Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 25:402-408.
31. Kitchen I, Leslie FM, Kelly M, Barnes R, Crook TJ, Hill RG, et al. (1995): Development of delta-opioid receptor subtypes and the regulatory role of weaning: Radioligand binding, autoradiography and in situ hybridization studies. J Pharmacol Exp Ther 275:1597-1607.
32. Pradhan AA, Becker JA, Scherrer G, Tryoen-Toth P, Filliol D, Matifas A, et al. (2009): In vivo delta opioid receptor internalization controls behavioral effects of agonists. PLoS One 4:e5425.
33. Le Merrer J, Rezai X, Scherrer G, Becker JA, Kieffer BL (2013): Impaired hippocampus-dependent and facilitated striatum-dependent behaviors in mice lacking the delta opioid receptor. Neuropsychopharmacology 38:1050-1059.
34. Nozaki C, Le Bourdonnec B, Reiss D, Windh RT, Little PJ, Dolle RE, et al. (2012): Delta-opioid mechanisms for ADL5747 and ADL5859 effects in mice: Analgesia, locomotion, and receptor internalization. J Pharmacol Exp Ther 342:799-807.
35. Le Merrer J, Gavello-Baudy S, Galey D, Cazala P (2007): Morphine self-administration into the lateral septum depends on dopaminergic mechanisms: Evidence from pharmacology and Fos neuroimaging. Behav Brain Res 180:203-217.
36. Margolis EB, Fields HL, Hjelmstad GO, Mitchell JM (2008): Delta-opioid receptor expression in the ventral tegmental area protects against elevated alcohol consumption. J Neurosci 28:12672-12681.
37. Stumm RK, Zhou C, Schulz S, Hollt V (2004): Neuronal types expressing mu- And delta-opioid receptor mRNA in the rat hippocampal formation. J Comp Neurol 469:107-118.
38. Monory K, Massa F, Egertova M, Eder M, Blaudzun H, Westenbroek R, et al. (2006): The endocannabinoid system controls key epileptogenic circuits in the hippocampus. Neuron 51:455-466.
39. Jutkiewicz EM, Kaminsky ST, Rice KC, Traynor JR, Woods JH (2005): Differential behavioral tolerance to the delta-opioid agonist SNC80 ([(1)-4-[(alphaR)-alpha-[(2S, 5R)-2, 5-dimethyl-4-(2-propenyl)-1-piperazinyl]-( 3-me thoxyphenyl)methyl]-N, N-diethylbenzamide) in Sprague- Dawley rats. J Pharmacol Exp Ther 315:414-422.
40. Song C, Leonard BE (2005): The olfactory bulbectomised rat as a model of depression. Neurosci Biobehav Rev 29:627-647.
41. Bewernick BH, Kayser S, Sturm V, Schlaepfer TE (2012): Long-term effects of nucleus accumbens deep brain stimulation in treatmentresistant depression: Evidence for sustained efficacy. Neuropsychopharmacology 37:1975-1985.
42. Roberts AJ, Gold LH, Polis I, McDonald JS, Filliol D, Kieffer BL, et al. (2001): Increased ethanol self-administration in delta-opioid receptor knockout mice. Alcohol Clin Exp Res 25:1249-1256.
43. Davis M, Whalen PJ (2001): The amygdala: Vigilance and emotion. Mol Psychiatry 6:13-34.
44. LeDoux JE (2000): Emotion circuits in the brain. Annu Rev Neurosci 23:155-184.
45. Santarelli L, Saxe M, Gross C, Surget A, Battaglia F, Dulawa S, et al. (2003): Requirement of hippocampal neurogenesis for the behavioral effects of antidepressants. Science 301:805-809.
46. Dulawa SC, Hen R (2005): Recent advances in animal models of chronic antidepressant effects: The novelty-induced hypophagia test. Neurosci Biobehav Rev 29:771-783.
47. Dragunow M, Faull R (1989): The use of c-fos as a metabolic marker in neuronal pathway tracing. J Neurosci Methods 29:261-265.
48. Buot A, Yelnik J (2012): Functional anatomy of the basal ganglia: Limbic aspects. Rev Neurol (Paris) 168:569-575.
49. Christie MJ, Summers RJ, Stephenson JA, Cook CJ, Beart PM (1987): Excitatory amino acid projections to the nucleus accumbens septi in the rat: A retrograde transport study utilizing D[3H]aspartate and [3H] GABA. Neuroscience 22:425-439.
50. Stuber GD, Sparta DR, Stamatakis AM, van Leeuwen WA, Hardjoprajitno JE, Cho S, et al. (2011): Excitatory transmission from the amygdala to nucleus accumbens facilitates reward seeking. Nature 475:377-380.
51. Yee CL, Wang Y, Anderson S, Ekker M, Rubenstein JL (2009): Arcuate nucleus expression of NKX2.1 and DLX and lineages expressing these transcription factors in neuropeptide Y(1), proopiomelanocortin(1), and tyrosine hydroxylase(1) neurons in neonatal and adult mice. J Comp Neurol 517:37-50.
52. Saitoh A, Sugiyama A, Nemoto T, Fujii H, Wada K, Oka J, et al. (2011): The novel delta opioid receptor agonist KNT-127 produces antidepressant- like and antinociceptive effects in mice without producing convulsions. Behav Brain Res 223:271-279.
53. Durieux PF, Schiffmann SN, de Kerchove d'Exaerde A (2012): Differential regulation of motor control and response to dopaminergic drugs by D1R and D2R neurons in distinct dorsal striatum subregions. EMBO J 31:640-653.
54. Le Merrer J, Plaza-Zabala A, Boca CD, Matifas A, Maldonado R, Kieffer BL (2011): Deletion of the delta opioid receptor gene impairs place conditioning but preserves morphine reinforcement. Biol Psychiatry 69:700-703.
55. Kelly JP, Wrynn AS, Leonard BE (1997): The olfactory bulbectomized rat as a model of depression: An update. Pharmacol Ther 74: 299-316.
56. Saitoh A, Kimura Y, Suzuki T, Kawai K, Nagase H, Kamei J (2004): Potential anxiolytic and antidepressant-like activities of SNC80, a selective delta-opioid agonist, in behavioral models in rodents. J Pharmacol Sci 95:374-380.
57. Ramos A (2008): Animal models of anxiety: Do I need multiple tests? Trends Pharmacol Sci 29:493-498.
58. File SE, Lippa AS, Beer B, Lippa MT (2004): Animal tests of anxiety. Curr Protoc Neurosci Chapter 8:Unit 8 3.
59. Adamec R, Toth M, Haller J, Halasz J, Blundell J (2012): A comparison of activation patterns of cells in selected prefrontal cortical and amygdala areas of rats which are more or less anxious in response to predator exposure or submersion stress. Physiol Behav 105:628-638.
60. Davidson RJ (2002): Anxiety and affective style: Role of prefrontal cortex and amygdala. Biol Psychiatry 51:68-80.
61. Saitoh A, Yoshikawa Y, Onodera K, Kamei J (2005): Role of deltaopioid receptor subtypes in anxiety-related behaviors in the elevated plus-maze in rats. Psychopharmacology (Berl) 182:327-334.
62. Paxinos G, Franklin KBJ. The mouse brain in stereotaxic coordinates. Academic press: New York, 2001.
63. Perrine SA, Hoshaw BA, Unterwald EM (2006): Delta opioid receptor ligands modulate anxiety-like behaviors in the rat. Br J Pharmacol 147:864-872.
64. Vergura R, Balboni G, Spagnolo B, Gavioli E, Lambert DG, McDonald J, et al. (2008): Anxiolytic- And antidepressant-like activities of H-Dmt- Tic-NH-CH(CH2-COOH)-Bid (UFP-512), a novel selective delta opioid receptor agonist. Peptides 29:93-103.
65. Refojo D, Schweizer M, Kuehne C, Ehrenberg S, Thoeringer C, Vogl AM, et al. (2011): Glutamatergic and dopaminergic neurons mediate anxiogenic and anxiolytic effects of CRHR1. Science 333: 1903-1907.
66. Callaway CW, Hakan RL, Henriksen SJ (1991): Distribution of amygdala input to the nucleus accumbens septi: An electrophysiological investigation. J Neural Transm Gen Sect 83:215-225.